POM-V Prescription Required Companion Animal

ERAVAC Emulsion for Injection for Rabbits

Active ingredient: Rabbit haemorrhagic disease virus type 2

Form

Injection

Species

Rabbits

Manufacturer

Laboratorios Hipra SA

VMD MA No.

EU/2/16/199/001-004

What it's used for

For active immunisation of rabbits from the age of 30 days to reduce mortality caused by the rabbit haemorrhagic disease type 2 virus (RHDV2). Onset of imm...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Rabbit haemorrhagic disease...

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

ERAVAC Emulsion for Injection for Rabbits — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

For active immunisation of rabbits from the age of 30 days to reduce mortality caused
by the rabbit haemorrhagic disease type 2 virus (RHDV2).
Onset of immunity: 1 week.
Duration of immunity: 12 months demonstrated by challenge

Subcutaneous use.
Administer 1 dose (0.5 ml) of the vaccine to rabbits from the age of 30 days by
subcutaneous injection in the lateral thoracic wall.
Revaccination: every 12 months after the last vaccination.
Before use allow the vaccine to reach room temperature.
Shake well before administration.

Do not use in cases of hypersensitivity to the active substance, to the adjuvant or to
any of the excipients.

Issued: September 2021
AN: 01737/2020

A transient temperature increase slightly above 40 ºC between two or three days
following vaccination was observed very commonly during safety studies. This slight
temperature increase resolves spontaneously without treatment by day 5 post
vaccination.
Nodules or swellings (< 2 cm) at the injection site were observed very commonly
during safety studies. These local reactions may last 24 hours and gradually reduce
and disappear without need for treatment.
Lethargy and/or inappetence in the first 48 hours after injection may be observed
very rarely , based on post-authorisation pharmacovigilance reporting.
The frequency of adverse reactions is defined using the following convention:
-very common (more than 1 in 10 animals treated displaying adverse reaction (s)
-common (more than 1 but less than 10 animals in 100 animals treated)
-uncommon (more than 1 but less than 10 animals in 1,000 animals treated)
-rare (more than 1 but less than 10 animals in 10,000 animals treated)
-very rare (less than 1 animal in 10,000 animals treated, including isolated reports).

Issued: September 2021
AN: 01737/2020

The vaccine provides protection only against RHDV2, cross protection against
classical RHDV has not been demonstrated.
Vaccinate healthy animals only.

Special precautions for use in animals
Vaccination is recommended where RHDV2 is epidemiologically relevant.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
To the user:
This veterinary medicinal product contains mineral oil. Accidental injection/self-
injection may result in severe pain and swelling, particularly if injected into a joint or
finger, and in rare cases could result in the loss of the affected finger if prompt
medical attention is not given. If you are accidentally injected with this veterinary
medicinal product, seek prompt medical advice even if only a very small amount is
injected and take the package leaflet with you. If pain persists for more than 12 hours
after medical examination, seek medical advice again.
To the physician:
This veterinary medicinal product contains mineral oil. Even if small amounts have
been injected, accidental injection with this product can cause intense swelling, which
may, for example, result in ischaemic necrosis and even the loss of a digit. Expert,
PROMPT, surgical attention is required and may necessitate early incision and
irrigation of the injected area, especially where there is involvement of finger pulp or
tendon.

No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product. A decision to use this vaccine before or after
any other veterinary medicinal product therefore needs to be made on a case by
case basis.

Store and transport refrigerated (2 ºC–8 ºC).
Do not freeze.
Keep the vial(s) in the outer carton in order to protect from light.

Zero days.
5. IMMUNOLOGICAL PROPERTIES
Pharmacotherapeutic group: Inactivated viral vaccines for Leporidae, inactivated viral
vaccine for rabbits, rabbit haemorrhagic disease virus.
ATCvet code: QI08AA01
To stimulate active immunity against the rabbit haemorrhagic disease type 2 virus
(RHDV2).
Vaccination of rabbits induced the production of hemagglutination inhibition
antibodies that persisted for at least 12 months.

Issued: September 2021
AN: 01737/2020

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.